Guardian Approval Should Give Medtronic Sizable Lead In CGMS Market
FDA approval of Medtronic's Guardian continuous glucose monitoring system gives the firm a headstart on primary competitor TheraSense's FreeStyle Navigator CGMS
FDA approval of Medtronic's Guardian continuous glucose monitoring system gives the firm a headstart on primary competitor TheraSense's FreeStyle Navigator CGMS